noted that the regulatory networks of XBP1s follow a cell type‐ and condition‐specific manner.[41] Therefore, the molecular mechanism governing XBP1s‐E2F1 regulation in HR+/HER2− breast cancer requires further investigation. This evidence concerns the gene E2F1 and breast carcinoma.